FONAR Corporation
HealthcareNASDAQ:FONR · NASDAQ Capital Market
+$0.00 today
Vol 0.00M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+31.20%
Period High
$19.11
Period Low
$14.03
Latest
$19.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$211.08M
Apyx Medical Corporation
NASDAQ:APYX
$196.39M
Edap Tms S.a.
EDAP
$178.23M
Quipt Home Medical Corp.
QIPT
$162.30M
InflaRx N.V.
NASDAQ:IFRX
$115.57M
Hyperfine, Inc.
NASDAQ:HYPR
$114.53M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Vivani Medical, Inc.
NASDAQ:VANI
$64.99M
Pulmonx Corporation
NASDAQ:LUNG
$57.86M
InspireMD, Inc.
NSPR
$34.19M
What is the latest FONR filing?
The latest filing shown is SC 13G dated Jun 10, 2026.
How many recent filings does FONR have?
Intrinsic Alpha currently shows 20 recent filings for FONR.
Explore More
Continue the stock analysis
Jump to another research area for this company.